GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
10.60
+0.91 (9.39%)
At close: Jan 31, 2025, 4:00 PM
11.75
+1.15 (10.85%)
After-hours: Jan 31, 2025, 7:48 PM EST
GH Research Market Cap
GH Research has a market cap or net worth of $551.50 million as of January 31, 2025. Its market cap has increased by 84.69% in one year.
Market Cap
551.50M
Enterprise Value
358.39M
1-Year Change
84.69%
Ranking
Category
Stock Price
$10.60
Market Cap Chart
Since the IPO on June 25, 2021, GH Research's market cap has decreased from $808.33M to $551.50M, a decrease of -31.77%. That is a compound annual growth rate of -10.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 31, 2025 | 551.50M | 51.43% |
| Dec 31, 2024 | 364.20M | 20.71% |
| Dec 29, 2023 | 301.72M | -40.33% |
| Dec 30, 2022 | 505.64M | -58.34% |
| Dec 31, 2021 | 1.21B | 50.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 740.89B |
| UnitedHealth Group | 504.58B |
| Novo Nordisk | 374.46B |
| Johnson & Johnson | 367.50B |
| AbbVie | 331.82B |
| Merck & Co. | 251.71B |
| Thermo Fisher Scientific | 231.19B |
| Abbott Laboratories | 222.57B |